about
Synthesis and pharmacological evaluation of some 3-(4-methylphenyl)-2-substituted amino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agentsChiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin.Multitargeting by curcumin as revealed by molecular interaction studiesPharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses.Nonsteroidal antiinflammatory drugs inhibiting prostanoid efflux: as easy as ABC?Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial.Nigella sativa: A Potential Antiosteoporotic AgentAttenuation of the development of hypercholesterolemic atherosclerosis by thymoquinone.Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors.Convergent synthesis and evaluation of (18)F-labeled azulenic COX2 probes for cancer imaging.Arachidonic acid: an evolutionarily conserved signaling molecule modulates plant stress signaling networks.Synthesis and evaluation of novel 2-substituted-quinazolin-4(3H)-ones as potent analgesic and anti-inflammatory agents.Synthesis and pharmacological evaluation of 3-cyclohexyl-2-substituted hydrazino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents.Molecular interactions of isoxazolcurcumin with human serum albumin: spectroscopic and molecular modeling studies.Synthesis, anti-inflammatory and analgesic evaluation of certain new 3a,4,9,9a-tetrahydro-4,9-benzenobenz[f]isoindole-1,3-diones.Molecular docking analysis of curcumin analogues with COX-2.Novel 4-methylsulfonylphenyl derivatives as NSAIDS with preferential COX-2 inhibition.Anti-inflammatory and analgesic activities of cupressuflavone from Cupressus macrocarpa: Impact on pro-inflammatory mediators.[A heterogenous drug class. NSAID: classification and spectrum of action].The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2Synthase
P2860
Q28213894-6D7C8903-EB76-43C7-8561-2AD25E8E119FQ33851532-3A738E1D-F2C1-41E0-BC04-92394223FF84Q34042485-3FBDAA92-8EB8-4BA9-AC4B-E9DF29598214Q34579145-C618DD40-684F-4A85-9533-4353E605107BQ35234114-D78F3769-4C61-4771-9EC5-3FE748A759EEQ36204500-25030D86-F0E2-43DB-9085-B72423C253CDQ36225602-26047B0B-A0E5-4DE8-BB0B-83A16C3C018FQ37310484-53C272ED-83FA-4622-A411-B47BB269C1C8Q38732477-EEB7405D-05C1-4711-B5FA-A9896790BB05Q41859354-7E4387B3-F54C-45D2-B983-D57AD4EEE6B1Q42863289-2E33447C-6167-40D5-AABE-9FCEBD90B0B8Q43182221-31E03661-387F-4F9C-95E4-6210C36AA89BQ46079351-72B6262B-50EE-4E0A-8499-5FA442994136Q46349516-2BB85FFE-CF03-4E5C-B199-600BAAEDA2B1Q46978390-B56EEED3-617F-4B5F-8677-D789285D2005Q47094115-5ACDBDAB-5EAD-4D89-8272-EB9FE7C72A5BQ47784462-AB0EB78F-84A4-4BD0-813A-2DF6A476AE73Q48318439-CCA8955A-0A5E-40DE-A42F-964D60454EAAQ53923486-BC192E0E-3CAB-4F2F-8B4D-76FA1161BB70Q59054771-CA52E633-2515-407E-A65A-6B6A76AD27F2
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
COX-2 selectivity and inflammatory processes.
@ast
COX-2 selectivity and inflammatory processes.
@en
COX-2 selectivity and inflammatory processes.
@nl
type
label
COX-2 selectivity and inflammatory processes.
@ast
COX-2 selectivity and inflammatory processes.
@en
COX-2 selectivity and inflammatory processes.
@nl
prefLabel
COX-2 selectivity and inflammatory processes.
@ast
COX-2 selectivity and inflammatory processes.
@en
COX-2 selectivity and inflammatory processes.
@nl
P2093
P356
P1476
COX-2 selectivity and inflammatory processes.
@en
P2093
P304
P356
10.2174/0929867003374255
P577
2000-11-01T00:00:00Z